CEL-SCI Corporation

    Jurisdiction
    United States
    LEI
    549300FIWOFSETIVMI17
    ISIN
    US1508376076 (CVM)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€15.88M
    EBIT margin
    0.0%
    Net income
    -€16.18M
    Net margin
    0.0%

    Statement period: - (published )

    Dividends

    Last dividend amount
    $0.25
    Ex date

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    KERSTEN GEERT R Chief Executive Officer +29K $6.85 +$200.00K
    Watson Robert Eugene N/A +2.9K $6.85 +$20.00K

    Add to watchlist

    Notifications